Sign in
Taking peopleNo phase

Probiotics added to metformin or insulin for gestational diabetes

Tests probiotics added to usual diabetes medicine in women with gestational diabetes.

Key facts

Who runs it
Riphah International University
Where
Pakistan1 site in 1 countryChoose a country to see its sites
Trial code
Registry title
Therapeutic Synergy of Probiotic Augmented Conventional Antidiabetic Pharmacotherapy in Gestational Diabetes Mellitus
Status
Recruiting
People taking part
200 people, planned
Started
29 Jul 2026
Expected to end
Jun 2027
Type of study
Interventional, 4 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • GRP 1 Tab metformin
  • GRP 2 Inj insulin
  • GRP 3 Tab metformin + HI flora sachet
  • GRP 4 Inj insulin + HI flora sachet
Record updated
30 July 2026

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for pregnant women with diabetes that started in pregnancy (gestational diabetes). It compares metformin or insulin, with or without a probiotic sachet.

Age
18 to 45 years
Sex
Women only
Disease stage
Gestational diabetes diagnosed between 18-26 weeks of pregnancy. Pregnant with one baby only.
Earlier treatment
Cannot join if antibiotics or probiotics were used within the previous 4 weeks.

Main reasons for not taking part

  • Diabetes that existed before the pregnancy
  • High blood pressure caused by pregnancy
  • Long-term bowel, liver or kidney disease
  • Pregnant with more than one baby
  • Known abnormalities in the unborn baby

This trial only enrols pregnant participants. The registry sentence this rests on: * Pregnant women (18-45 years of age).

The registry criteria, word for word

Show all 9 criteriaShow less

Who can take part

  • Pregnant women (18-45 years of age)
  • Diagnosed with GDM between 18-26 weeks of gestation
  • Singleton pregnancy. (Multiple gestations carry inherently higher risks like preterm birth, growth restriction and neonatal morbidity, Inclusion may introduce confounding thus restricting singleton pregnancies ensures population homogeneity)

Who cannot take part

  • Use of antibiotics or probiotics within the previous 4 weeks
  • Pre-existing diabetes mellitus
  • Pregnancy induced hypertension
  • Chronic gastrointestinal, hepatic, or renal disease
  • Multiple pregnancy
  • Pregnancy with known fetal anomalies

The main criteria, as questions

Answer for yourself. This is not a decision: only the study team can say whether you can take part.

  • Are you between 18 and 45 years old?

This trial has no sites in United States.

It has sites in one country. Choose a country to see its sites.

About the trial

What the trial wants to find out

1. To compare the effects of metformin, insulin, and their combination with multistrain probiotics on glycemic control and insulin resistance in women with gestational diabetes mellitus (GDM), assessed by FPG, HbA1c, fasting insulin, and HOMA-IR. 2. To compare the effects of metformin, insulin, and their combination with multistrain probiotics on inflammatory biomarkers in women with GDM. 3. To determine the effect of multistrain probiotic supplementation alongside standard therapy on maternal and neonatal outcomes, including gestational age at delivery, mode of delivery, birth weight, Apgar score, and NICU admission.

The 4 groups in the trial

  • GRP 1 Tab metforminExisting treatment, for comparison
  • GRP 2 Inj insulinExisting treatment, for comparison
  • GRP 3 Tab metformin + HI flora sachetTreatment being tested
  • GRP 4 Inj insulin + HI floraTreatment being tested

    Treatment: GRP 4 Inj insulin + HI flora sachet

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Therapeutic Synergy of Probiotic Augmented Conventional Antidiabetic Pharmacotherapy in Gestational Diabetes Mellitus
Plain-language title
Probiotics added to metformin or insulin for gestational diabetesGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 15 November 2026.
Criteria questions
Built from NCT07645001, who can take part
Record updated
30 July 2026